from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2931/ppsA

LFCtreatmentdescriptionclass of inhibitor

-1.572

Amikacinug/mL Amikacintranslation

-0.947

Cap5-10ug/mL Capreomycintranslation

-0.926

Rox10-50 ug/mL Roxithromycintranslation

-0.724

SM2-5 ug/mL Streptomycintranslation

-2.583

Tet5-10 ug/mL Tetracyclinetranslation

0.153

Rif0.2-5ug/mL Rifampicintranscription

-0.151

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.117

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.192

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.413

CPZ10-50 ug/mL Chlorpromazinerespiration

0.623

Clofazimine10-13 ug/mL Clofaziminerespiration

0.021

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.778

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.140

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.776

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.017

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.596

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.056

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.093

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.178

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.002

KCN5-20 ug/mL Potassium cyaniderespiration

0.050

NaN30.2-2 mM Sodium aziderespiration

1.218

Nigericin50 uM Nigericinrespiration

-0.900

TRC10-150 ug/mL Triclosanrespiration

-0.401

TRZ10-25 ug/mL Thioridazinerespiration

0.826

Valinomycin0.5-10 uM Valinomycinrespiration

0.389

ZnSO42 mM ZnSO4respiration

-0.344

menadione6-10 ug/mL Menadionerespiration

1.294

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.535

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.169

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.377

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.995

NRP_1Non-replicating persistence stage 1dosRassociated

0.459

Amp0.2mg/mL AmpicillincellWall

0.182

Cephalexin20-100 ug/mL CephalexincellWall

1.413

Cerulenin0.32-5 ug/mL CerulenincellWall

0.567

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.922

EMB10-20 ug/mL EthambutolcellWall

0.551

Eta12-40 ug/mL EthionamidecellWall

0.727

INH0.2-0.4 ug/mL IsoniazidcellWall

0.788

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.911

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.190

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.618

BZA0.12 mg/mL BenzamidearomaticAmides

-0.509

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.254

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.007

H2O24 mM hydrogen peroxideDNAdamaging

-0.208

Levo10 ug/mL LevofloxacinDNAdamaging

-0.031

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.526

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.432

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.111

UVUV-irradiationDNAdamaging

-1.976

ARP41-4 ug/mL Antitubercular compound ARP4?

0.212

Antimycin12.5-50 ug/mL Antimycin A?

0.174

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.518

PA_110-50 ug/mL Antitubercular compound PA-1?

0.035

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.162

PA8240.2-2 ug/mL PA-824?

0.771

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.178

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.484

Verapamil50 uM Verapamil?

-0.451

mercaptoethanol2 mM 2-Mercaptoethanol?

0.483

methoxatin10-20 ug/mL Methoxatin?